Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard D Moore

Showing results (31-40 of 500) with videos related to

Pageof 50
Sort By:
AIDS and Behavior|March 16, 2018
Time Spent with HIV Viral Load > 1500 Copies/mL Among Persons Engaged in Continuity HIV Care in an Urban Clinic in the United States, 2010-2015Catherine R Lesko, Bryan Lau, Geetanjali Chander, et al.
AIDS and Behavior|October 19, 2016
Retention, Antiretroviral Therapy Use and Viral Suppression by History of Injection Drug Use Among HIV-Infected Patients in an Urban HIV Clinical CohortCatherine R Lesko, Weiqun Tong, Richard D Moore, et al.
Journal of Clinical Epidemiology|July 23, 2003
Multivariate estimation of cumulative incidence, prevalence, and morbidity time of a disease when death is likelyYan Yan, Donald R Hoover, Richard D Moore, et al.
AIDS (London, England)|October 17, 2018
Death after diagnosis of noncommunicable disease comorbid conditions, stratified by injection drug useCatherine R Lesko, Bryan Lau, Geetanjali Chander, et al.
AIDS Research and Therapy|July 27, 2010
Identifying individuals with virologic failure after initiating effective antiretroviral therapy: The surprising value of mean corpuscular hemoglobin in a cross-sectional studyBryan Lau, Geetanjali Chander, Stephen J Gange, et al.
AIDS Research and Human Retroviruses|September 22, 2010
HIV-1 diversity after a class switch failureMichael A Kolber, Patricia Buendia, Victor Degruttola, et al.
AIDS (London, England)|March 19, 2016
Association of injection drug use with incidence of HIV-associated non-AIDS-related morbidity by age, 1995-2014Catherine R Lesko, Richard D Moore, Weiqun Tong, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 17, 2004
Does the presence of a current psychiatric disorder in AIDS patients affect the initiation of antiretroviral treatment and duration of therapy?Seth Himelhoch, Richard D Moore, Glenn Treisman, et al.
AIDS Patient Care and Stds|June 29, 2010
Trust in physicians and racial disparities in HIV careSomnath Saha, Elizabeth A Jacobs, Richard D Moore, et al.
The Journal of Infectious Diseases|November 26, 2003
Improved outcomes with earlier initiation of highly active antiretroviral therapy among human immunodeficiency virus-infected patients who achieve durable virologic suppression: longer follow-up of an observational cohort studyTimothy R Sterling, Richard E Chaisson, Jeanne Keruly, et al.
Pageof 50

Showing results (31-40 of 500) with videos related to

Sort By:
Pageof 50
AIDS and Behavior|March 16, 2018
Time Spent with HIV Viral Load > 1500 Copies/mL Among Persons Engaged in Continuity HIV Care in an Urban Clinic in the United States, 2010-2015Catherine R Lesko, Bryan Lau, Geetanjali Chander, et al.
AIDS and Behavior|October 19, 2016
Retention, Antiretroviral Therapy Use and Viral Suppression by History of Injection Drug Use Among HIV-Infected Patients in an Urban HIV Clinical CohortCatherine R Lesko, Weiqun Tong, Richard D Moore, et al.
Journal of Clinical Epidemiology|July 23, 2003
Multivariate estimation of cumulative incidence, prevalence, and morbidity time of a disease when death is likelyYan Yan, Donald R Hoover, Richard D Moore, et al.
AIDS (London, England)|October 17, 2018
Death after diagnosis of noncommunicable disease comorbid conditions, stratified by injection drug useCatherine R Lesko, Bryan Lau, Geetanjali Chander, et al.
AIDS Research and Therapy|July 27, 2010
Identifying individuals with virologic failure after initiating effective antiretroviral therapy: The surprising value of mean corpuscular hemoglobin in a cross-sectional studyBryan Lau, Geetanjali Chander, Stephen J Gange, et al.
AIDS Research and Human Retroviruses|September 22, 2010
HIV-1 diversity after a class switch failureMichael A Kolber, Patricia Buendia, Victor Degruttola, et al.
AIDS (London, England)|March 19, 2016
Association of injection drug use with incidence of HIV-associated non-AIDS-related morbidity by age, 1995-2014Catherine R Lesko, Richard D Moore, Weiqun Tong, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 17, 2004
Does the presence of a current psychiatric disorder in AIDS patients affect the initiation of antiretroviral treatment and duration of therapy?Seth Himelhoch, Richard D Moore, Glenn Treisman, et al.
AIDS Patient Care and Stds|June 29, 2010
Trust in physicians and racial disparities in HIV careSomnath Saha, Elizabeth A Jacobs, Richard D Moore, et al.
The Journal of Infectious Diseases|November 26, 2003
Improved outcomes with earlier initiation of highly active antiretroviral therapy among human immunodeficiency virus-infected patients who achieve durable virologic suppression: longer follow-up of an observational cohort studyTimothy R Sterling, Richard E Chaisson, Jeanne Keruly, et al.
Pageof 50